Life Sciences researchers have been awarded £3.19m in funding to support a flagship project into antimicrobial resistance (AMR).

The funding will enable multi-partner collaborations in order to tackle the growing threat of superbugs as part of a co-ordinated multi-disciplinary effort to fight their prevalence.

Awarded by a cross research council ‘war cabinet’ on AMR comprising the Medical Research Council (MRC) and the Biological Sciences Research Council (BBSRC), the funding marks one of the largest UK public grant investments in AMR research.

Researchers Prof Chris Dowson, Dr David Roper, Dr Adrian Lloyd from the School of Life Sciences and Prof Matthew Turner of the Department of Physics, will investigate a vital link in the chain of antimicrobial resistance – the bacterial cell wall. The main component of the wall is called peptidoglycan, which is the key target of penicillin and other similar antibiotics.

Press Release